个人中心 - 老虎社区

shanshan88

IP属地：未知

帖子 · 28帖子 · 28
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- shanshan88shanshan88
  ·2021-12-23
  Thanks
  Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth
  (Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its f
  Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth
  1,357 评论
  1
  分享
  举报
- shanshan88shanshan88
  ·2021-11-08
  Like pls
  FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment
  Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Ep
  FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment
  919 评论
  1
  分享
  举报
- shanshan88shanshan88
  ·2021-11-06
  Like pls
  非常抱歉，此主贴已删除
  1,144 1
  2
  分享
  举报
- shanshan88shanshan88
  ·2021-09-27
  Like pls
  非常抱歉，此主贴已删除
  1,026 1
  1
  分享
  举报
- shanshan88shanshan88
  ·2021-09-27
  Like pls
  非常抱歉，此主贴已删除
  796 评论
  点赞
  分享
  举报
- shanshan88shanshan88
  ·2021-07-04
  立刻
  非常抱歉，此主贴已删除
  795 评论
  1
  分享
  举报
- shanshan88shanshan88
  ·2021-05-29
  Like
  非常抱歉，此主贴已删除
  335 评论
  点赞
  分享
  举报
- shanshan88shanshan88
  ·2021-05-28
  Like
  非常抱歉，此主贴已删除
  542 1
  2
  分享
  举报
- shanshan88shanshan88
  ·2021-05-28
  Like
  Nutanix Posts Smaller-Than-Feared Quarterly Loss, Revenue Beats Estimates
  Nutanix (NTNX) reported a smaller-than-expected loss in the fiscal third quarter. Nutanix is a cloud
  Nutanix Posts Smaller-Than-Feared Quarterly Loss, Revenue Beats Estimates
  550 评论
  1
  分享
  举报
- shanshan88shanshan88
  ·2021-05-22
  Comment n like
  非常抱歉，此主贴已删除
  571 评论
  点赞
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3577599976368524","uuid":"3577599976368524","gmtCreate":1614505952934,"gmtModify":1614509444122,"name":"shanshan88","pinyin":"shanshan88","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":524,"tweetSize":28,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698058112,"gmtCreate":1640267707374,"gmtModify":1640267882397,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698058112","repostId":"1197097469","repostType":4,"repost":{"id":"1197097469","kind":"news","pubTimestamp":1640265594,"share":"https://www.laohu8.com/m/news/1197097469?lang=&edition=full","pubTime":"2021-12-23 21:19","market":"us","language":"en","title":"Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1197097469","media":"Bloomberg","summary":"(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its f","content":"<p>(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its fast-growing business of offbeat footwear.</p>\n<p>The purchase will be funded by $2.05 billion in cash and $450 million in Crocs shares issued to Heydude founder Alessandro Rosano, according to a statement Thursday. Crocs said it expects the deal to immediately add to its sales growth and earnings, while the combined operations will generate “significant” free cash flow.</p>\n<p>The agreement underscores the rapid expansion of Crocs’ business as its once-derided foam clogs catch on with a hip Gen Z crowd. Crocs has said it expects revenue growth of as much as 65% this year. Heydude, which will operate as a stand-alone division, makes lightweight, casual shoes and sandals for men, women and children.</p>\n<p>Crocs shares fell 3.5% as of 7:17 a.m. before regular trading in New York. The stock soared 123% this year through Wednesday’s close.</p>\n<p>The deal for closely held Heydude is expected to close in the first quarter. Crocs expects to fund the cash component with a $2 billion term loan B facility and borrow $50 million under its existing senior revolving credit facility.</p>\n<p>Citi is financial adviser to Crocs, while Perkins Coie LLP and Bird &amp; Bird provide legal counsel. LVC Asia Pacific Ltd. is Heydude’s financial adviser, with Chiomenti, Deacons, Cozen O’Connor, Sullivan &amp; Cromwell and Croon Law Group LLC serving as legal counsel.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 21:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its fast-growing business of offbeat footwear.\nThe purchase will be funded by $2.05 billion in cash and $...</p>\n\n<a href=\"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CROX":"卡骆驰"},"source_url":"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197097469","content_text":"(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its fast-growing business of offbeat footwear.\nThe purchase will be funded by $2.05 billion in cash and $450 million in Crocs shares issued to Heydude founder Alessandro Rosano, according to a statement Thursday. Crocs said it expects the deal to immediately add to its sales growth and earnings, while the combined operations will generate “significant” free cash flow.\nThe agreement underscores the rapid expansion of Crocs’ business as its once-derided foam clogs catch on with a hip Gen Z crowd. Crocs has said it expects revenue growth of as much as 65% this year. Heydude, which will operate as a stand-alone division, makes lightweight, casual shoes and sandals for men, women and children.\nCrocs shares fell 3.5% as of 7:17 a.m. before regular trading in New York. The stock soared 123% this year through Wednesday’s close.\nThe deal for closely held Heydude is expected to close in the first quarter. Crocs expects to fund the cash component with a $2 billion term loan B facility and borrow $50 million under its existing senior revolving credit facility.\nCiti is financial adviser to Crocs, while Perkins Coie LLP and Bird & Bird provide legal counsel. LVC Asia Pacific Ltd. is Heydude’s financial adviser, with Chiomenti, Deacons, Cozen O’Connor, Sullivan & Cromwell and Croon Law Group LLC serving as legal counsel.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844055971,"gmtCreate":1636379888297,"gmtModify":1636380382936,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844055971","repostId":"1156155834","repostType":4,"repost":{"id":"1156155834","kind":"news","pubTimestamp":1636379472,"share":"https://www.laohu8.com/m/news/1156155834?lang=&edition=full","pubTime":"2021-11-08 21:51","market":"us","language":"en","title":"FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1156155834","media":"Benzinga","summary":"Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Ep","content":"<ul>\n <li><b>Eton Pharmaceuticals Inc</b>&nbsp;and&nbsp;<b>Azurity Pharmaceuticals Inc</b>&nbsp;have announced that the&nbsp;FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.</li>\n <li>Eprontia has been approved as a monotherapy for partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.</li>\n <li>The drug has also been approved as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older; and as a preventive treatment of migraine in patients 12 years of age and older.</li>\n <li>Eprontia is the first oral liquid formulation of topiramate to be approved by the FDA.</li>\n <li>Azurity will be responsible for commercializing the product, and it anticipates product availability by the end of 2021.</li>\n <li>Eton will receive a $5 million milestone payment upon Eprontia's commercial launch, a royalty on net sales, and potential commercial milestones.</li>\n <li><b>Price Action:</b>&nbsp;ETON shares are down 3.66% at $6.06&nbsp;during the premarket session on the last check Monday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-08 21:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.\nEprontia has been approved as a monotherapy for partial-...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETON":"Eton Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156155834","content_text":"Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.\nEprontia has been approved as a monotherapy for partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.\nThe drug has also been approved as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older; and as a preventive treatment of migraine in patients 12 years of age and older.\nEprontia is the first oral liquid formulation of topiramate to be approved by the FDA.\nAzurity will be responsible for commercializing the product, and it anticipates product availability by the end of 2021.\nEton will receive a $5 million milestone payment upon Eprontia's commercial launch, a royalty on net sales, and potential commercial milestones.\nPrice Action: ETON shares are down 3.66% at $6.06 during the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":919,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842679165,"gmtCreate":1636175305571,"gmtModify":1636176750956,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842679165","repostId":"1173813098","repostType":4,"isVote":1,"tweetType":1,"viewCount":1144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866129027,"gmtCreate":1632749033169,"gmtModify":1632798138441,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866129027","repostId":"2170264082","repostType":4,"isVote":1,"tweetType":1,"viewCount":1026,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866120784,"gmtCreate":1632749017548,"gmtModify":1632798138563,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866120784","repostId":"2170264082","repostType":4,"isVote":1,"tweetType":1,"viewCount":796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":155682446,"gmtCreate":1625412330485,"gmtModify":1631891812724,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"立刻","listText":"立刻","text":"立刻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155682446","repostId":"1160702483","repostType":4,"isVote":1,"tweetType":1,"viewCount":795,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":137364548,"gmtCreate":1622301837484,"gmtModify":1631891812730,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/137364548","repostId":"2138948877","repostType":4,"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134072236,"gmtCreate":1622196586925,"gmtModify":1631891812732,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/134072236","repostId":"2138109723","repostType":4,"isVote":1,"tweetType":1,"viewCount":542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134072317,"gmtCreate":1622196555239,"gmtModify":1631891812735,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/134072317","repostId":"2138109757","repostType":4,"repost":{"id":"2138109757","kind":"news","pubTimestamp":1622195924,"share":"https://www.laohu8.com/m/news/2138109757?lang=&edition=full","pubTime":"2021-05-28 17:58","market":"us","language":"en","title":"Nutanix Posts Smaller-Than-Feared Quarterly Loss, Revenue Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2138109757","media":"SmarterAnalyst","summary":"Nutanix (NTNX) reported a smaller-than-expected loss in the fiscal third quarter. Nutanix is a cloud","content":"<p>Nutanix (<b>NTNX</b>) reported a smaller-than-expected loss in the fiscal third quarter. Nutanix is a cloud computing company that sells software, cloud services, and software-defined storage.</p><p>The company incurred a loss of $0.41 per share in Q3, compared to the $0.49 loss per share estimated by analysts. A loss of $0.69 per share was reported in the same quarter last year.</p><p>Revenue generated in the quarter was $344.5 million which grew 8% from the year-ago period and outpaced analysts’ expectations of $334.5 million.</p><p>Annual Contract Value (ACV) billings were $159.9 million, up 18% year-over-year.</p><p>Nutanix’s CFO Duston Williams said, “Our growing renewals pipeline will help to drive future top line growth, offer substantial sales and marketing efficiencies, and increase the predictability in our business.” (See&nbsp;Nutanix stock analysis&nbsp;on TipRanks)</p><p>For the fourth quarter of Fiscal Year 2021, ACV billings are projected to be between $170 million and $175 million.</p><p>Following the fiscal Q3 earnings release, Susquehanna analyst&nbsp;Mehdi Hosseini&nbsp;increased the stock’s price target to $38.00 from $35.00 for 19.1% upside potential and reiterated a Buy rating.</p><p>Hosseini commented, “It is encouraging to see Nutanix continue to gain traction with AHV adoption, which has reached 52%, while ACV Billings continued to increase double digits Y/Y. We also expect cash burn to continue to moderate into FY22 with prospects of FCF BE by 4QFY22.”</p><p>Consensus among analysts is a Strong Buy based on 7 Buys versus 2 Holds. The average analyst&nbsp;price target stands at $41.13&nbsp;and implies upside potential of 28.9% to current levels. Shares have gained 39.7% over the past year.</p><p>TipRanks’ Stock Investors tool shows that&nbsp;investors&nbsp;currently have a Very Positive stance on Nutanix, with 7.5% of investors increasing their exposure to NTNX stock over the past 30 days.</p><p><img src=\"https://s1.yimg.com/uu/api/res/1.2/yAgFFR75COkoQHSIMLL_Gg--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/smarteranalyst_347/48e294ab2e492d22b314abc5f5ded1f0\" tg-width=\"609\" tg-height=\"436\" referrerpolicy=\"no-referrer\"></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nutanix Posts Smaller-Than-Feared Quarterly Loss, Revenue Beats Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNutanix Posts Smaller-Than-Feared Quarterly Loss, Revenue Beats Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-28 17:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/nutanix-posts-smaller-feared-quarterly-091344049.html><strong>SmarterAnalyst</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nutanix (NTNX) reported a smaller-than-expected loss in the fiscal third quarter. Nutanix is a cloud computing company that sells software, cloud services, and software-defined storage.The company ...</p>\n\n<a href=\"https://finance.yahoo.com/news/nutanix-posts-smaller-feared-quarterly-091344049.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NTNX":"Nutanix Inc."},"source_url":"https://finance.yahoo.com/news/nutanix-posts-smaller-feared-quarterly-091344049.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2138109757","content_text":"Nutanix (NTNX) reported a smaller-than-expected loss in the fiscal third quarter. Nutanix is a cloud computing company that sells software, cloud services, and software-defined storage.The company incurred a loss of $0.41 per share in Q3, compared to the $0.49 loss per share estimated by analysts. A loss of $0.69 per share was reported in the same quarter last year.Revenue generated in the quarter was $344.5 million which grew 8% from the year-ago period and outpaced analysts’ expectations of $334.5 million.Annual Contract Value (ACV) billings were $159.9 million, up 18% year-over-year.Nutanix’s CFO Duston Williams said, “Our growing renewals pipeline will help to drive future top line growth, offer substantial sales and marketing efficiencies, and increase the predictability in our business.” (See Nutanix stock analysis on TipRanks)For the fourth quarter of Fiscal Year 2021, ACV billings are projected to be between $170 million and $175 million.Following the fiscal Q3 earnings release, Susquehanna analyst Mehdi Hosseini increased the stock’s price target to $38.00 from $35.00 for 19.1% upside potential and reiterated a Buy rating.Hosseini commented, “It is encouraging to see Nutanix continue to gain traction with AHV adoption, which has reached 52%, while ACV Billings continued to increase double digits Y/Y. We also expect cash burn to continue to moderate into FY22 with prospects of FCF BE by 4QFY22.”Consensus among analysts is a Strong Buy based on 7 Buys versus 2 Holds. The average analyst price target stands at $41.13 and implies upside potential of 28.9% to current levels. Shares have gained 39.7% over the past year.TipRanks’ Stock Investors tool shows that investors currently have a Very Positive stance on Nutanix, with 7.5% of investors increasing their exposure to NTNX stock over the past 30 days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":550,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133043769,"gmtCreate":1621675025651,"gmtModify":1631891812738,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577599976368524","authorIdStr":"3577599976368524"},"themes":[],"htmlText":"Comment n like","listText":"Comment n like","text":"Comment n like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/133043769","repostId":"2137907575","repostType":4,"isVote":1,"tweetType":1,"viewCount":571,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":false}